Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 3/2012

01-06-2012 | Original Article

Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa

Authors: Yoichi Hirakata, Hisakazu Yano, Kazuaki Arai, Miho Kitagawa, Masumitsu Hatta, Hiroyuki Kunishima, Mitsuo Kaku

Published in: Journal of Infection and Chemotherapy | Issue 3/2012

Login to get access

Abstract

It is not clear whether antipseudomonal agents can kill cell-associated bacteria within a short time. Madin–Darby canine kidney (MDCK) and A549 cells were infected with Pseudomonas aeruginosa ATCC 27853 and PAO1 and the bactericidal activity of ceftazidime, imipenem, meropenem, gentamicin, and ciprofloxacin against the organisms was investigated. In both MDCK and A549 cells, β-lactams could not kill epithelial cell-associated bacteria within 2 h. Gentamicin at concentrations ≤32 μg/ml killed more than 99% of epithelial cell-associated bacteria. Ciprofloxacin at 0.5 μg/ml killed more than 99.9% of MDCK cell-associated bacteria. Ciprofloxacin has the strongest and most rapid bactericidal activity against epithelial cell-associated bacteria, which may be explained by the combination of potent in-vitro bactericidal activity and high penetration ability into epithelial cells.
Literature
1.
go back to reference Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents. 2002;19:261–8.PubMedCrossRef Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents. 2002;19:261–8.PubMedCrossRef
2.
go back to reference Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis. 1990;74 Suppl:63–70. Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis. 1990;74 Suppl:63–70.
3.
4.
go back to reference Hirakata Y, Finlay BB, Simpson DA, Kohno S, Kamihira S, Speert DP. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J Infect Dis. 2000;181:765–9.PubMedCrossRef Hirakata Y, Finlay BB, Simpson DA, Kohno S, Kamihira S, Speert DP. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J Infect Dis. 2000;181:765–9.PubMedCrossRef
5.
go back to reference Hirakata Y, Izumikawa K, Yamaguchi T, Igimi S, Furuya N, Maeasaki S, et al. Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa. Infect Immun. 1998;66:1748–51.PubMed Hirakata Y, Izumikawa K, Yamaguchi T, Igimi S, Furuya N, Maeasaki S, et al. Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa. Infect Immun. 1998;66:1748–51.PubMed
6.
go back to reference Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med. 2002;196:109–18.PubMedCrossRef Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med. 2002;196:109–18.PubMedCrossRef
7.
go back to reference Finlay BB, Gumbiner B, Falkow S. Penetration of Salmonella through a polarized Madin–Darby canine kidney epithelial cell monolayer. J Cell Biol. 1998;107:221–30.CrossRef Finlay BB, Gumbiner B, Falkow S. Penetration of Salmonella through a polarized Madin–Darby canine kidney epithelial cell monolayer. J Cell Biol. 1998;107:221–30.CrossRef
8.
go back to reference Fleiszig SM, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996;64:2288–94.PubMed Fleiszig SM, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996;64:2288–94.PubMed
9.
go back to reference Masuda N, Ohya S. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1992;36:1847–51.PubMed Masuda N, Ohya S. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1992;36:1847–51.PubMed
10.
go back to reference Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A8. Approved standard. 8th ed. Wayne: Clinical and Laboratory Standards Institute; 2009. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A8. Approved standard. 8th ed. Wayne: Clinical and Laboratory Standards Institute; 2009.
11.
go back to reference National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. Wayne: National Committee for Clinical Laboratory Standards; 1999. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. Wayne: National Committee for Clinical Laboratory Standards; 1999.
12.
go back to reference Dan M, Zabeeda D, Poch F. Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents. Chemotherapy. 1995;41:323–9.PubMedCrossRef Dan M, Zabeeda D, Poch F. Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents. Chemotherapy. 1995;41:323–9.PubMedCrossRef
13.
go back to reference Chadwick PR, Mellersh AR. The use of a tissue culture model to assess the penetration of antibiotics into epithelial cells. J Antimicrob Chemother. 1987;19:211–20.PubMedCrossRef Chadwick PR, Mellersh AR. The use of a tissue culture model to assess the penetration of antibiotics into epithelial cells. J Antimicrob Chemother. 1987;19:211–20.PubMedCrossRef
Metadata
Title
Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa
Authors
Yoichi Hirakata
Hisakazu Yano
Kazuaki Arai
Miho Kitagawa
Masumitsu Hatta
Hiroyuki Kunishima
Mitsuo Kaku
Publication date
01-06-2012
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 3/2012
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-011-0342-y

Other articles of this Issue 3/2012

Journal of Infection and Chemotherapy 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine